Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Anemia Drugs
... at a CAGR of 4.1% over the analysis period 2023-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the ... Read More
-
Endometriosis Drugs
... at a CAGR of 3.0% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Prescription Drugs
... at a CAGR of 5.7% over the analysis period 2023-2030. Generics, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$498.0 Billion by the end of the ... Read More
-
Global Age-Related Macular Degeneration Market Forecast Report by Disease Type (Dry Age-Related Macular Degeneration Market, Wet Age-Related Macular Degeneration Market) Product (Eylea, Lucentis, Beovu, Others) Distribution Channel (Hospital Pharmacy, Specialty Pharma, Online Pharmacy) Countries and Company Analysis, 2024-2032
... Company Analysis, 2024-2032 Age-Related Macular Degeneration Market Analysis The Global Age-Related Macular Degeneration market is forecasted to reach US$ 19.53 billion by 2032 from US$ 10.68 billion in 2023, and compound annual growth rate of ... Read More
-
Active Pharmaceutical Ingredients (API)
... reach US$358.5 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Innovative API, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach ... Read More
-
Pharmaceutical Wholesalers (EUROPEAN) - Industry Report
... PHARMACEUTICALS FRANCE, ALLIANCE HEALTHCARE ROMANIA S.R.L. and ASTRAZENECA AS. This report covers activities such as bio-pharmaceuticals, biopharmaceuticals, biologicals, biologics, vaccines and includes a wealth of information on the financial trends over the past four years. ... Read More
-
Pharmaceutical Wholesalers (GLOBAL) - Industry Report
... PHARMACEUTICALS FRANCE, ALLIANCE HEALTHCARE REPARTITION and APEX HEALTHCARE BERHAD. This report covers activities such as bio-pharmaceuticals, biopharmaceuticals, biologicals, biologics, vaccines and includes a wealth of information on the financial trends over the past four years. ... Read More
-
Anti-Obesity Drugs
... at a CAGR of 8.7% over the analysis period 2023-2030. Prescription Drugs, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$4.9 Billion by the end of ... Read More
-
Antibiotics
... of 3.1% over the analysis period 2023-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth ... Read More
-
Human Growth Hormone Drugs
... reach US$5.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach ... Read More
-
Pharmaceutical Manufacturers (SWEDEN) - Industry Report
... PRODUKTION & LABORATORIER AB, DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB and INDEX PHARMACEUTICALS HOLDING AB. This report covers activities such as bio-pharmaceuticals, biopharmaceuticals, biologicals, biologics, vaccines and includes a wealth of information on the financial trends ... Read More
-
Pain Management Drugs Market By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics) , By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain/Strain, Bone Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033 Pain Management Drugs Market The pain management drugs market was valued at $72.6 billion in 2023 ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Anti-Hypertensive Drugs
... at a CAGR of 2.8% over the analysis period 2023-2030. Calcium Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$7.2 Billion by the end ... Read More
-
Migraine Drugs
... at a CAGR of 16.1% over the analysis period 2023-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$7.2 Billion by the end of ... Read More
-
Tuberculosis Therapeutics
... at a CAGR of 2.7% over the analysis period 2023-2030. Active TB Therapeutics, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$654.3 Million by the end ... Read More
-
Hirsutism Treatment
... at a CAGR of 5.0% over the analysis period 2023-2030. Hirsutism Medications, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$2.4 Billion by the end of ... Read More
-
Growth Hormone Deficiency Market Size, Share & Segmentation, by Type, by Indication, by Distribution Channel, By Regions | Global Market Forecast 2024-2031
... insights into a specific market, industry, or sector. It involves the systematic collection, analysis, and interpretation of data related to market conditions, consumer behaviors, competitive landscapes, and emerging trends. The primary purpose of a market ... Read More
-
Drug Abuse Testing Market Report By Drug Type (Opioids, Cocaine, Alcohol, Cannabis/Marijauna, Amphetamine & Methaphetamine, LSD, Others), Product & Services (Consumables, Analysers, Rapid Testing Devices, Laboratory Services), Sample Type (Breath, Hair, Urine, Oral Fluid, Others), End Users (Rehabilitation Centers, Drug Testing Laboratories, Workplaces, Hospitals, Academic Institutes and Research Centers, Others) Countries and Company Analysis 2024-2032
... End Users (Rehabilitation Centers, Drug Testing Laboratories, Workplaces, Hospitals, Academic Institutes and Research Centers, Others) Countries and Company Analysis 2024-2032 Global Drug Abuse Testing Market Analysis Drug Abuse Testing Market will attain US$ 11.87 billion ... Read More
-
Pharmaceutical Wholesalers (NORDIC) - Industry Report
... RAPID DIAGNOSTICS A/S, ALMIRALL APS and ASTRAZENECA A/S. This report covers activities such as bio-pharmaceuticals, biopharmaceuticals, biologicals, biologics, vaccines and includes a wealth of information on the financial trends over the past four years. Plimsoll ... Read More
-
Doxorubicin
... of 5.8% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis ... Read More
-
Global Osteoporosis Drugs Market Report by Route of Administration (Injectable, Oral, Others) Product Type (Rank Ligand Inhibitor, Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, Others) Countries and Company Analysis, 2024-2032
... 2024-2032 Osteoporosis Drugs Market Analysis The osteoporosis drugs market is expected to over US$ 25.53 billion by 2032 from US$ 17.43 billion by 2023, with a CAGR growth of 4.33% from 2024 to 2032 because ... Read More
-
United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices and Pharmaceuticals), Pain Type, Drug Class, Indication, Distribution Channel and Company Analysis 2024-2032
... Therapeutics Market will reach US$ 36.15 billion by 2032, up from US$ 26.18 billion in 2023, with a CAGR of 3.65% between 2024 and 2032. Many factors are driving the market's rapid expansion such as ... Read More
-
Anti-Infectives
... of 6.2% over the analysis period 2023-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
Research Assistance
